BNP Paribas Financial Markets’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Buy
511,546
+385,546
+306% +$3.23M ﹤0.01% 2376
2026
Q1
$1.13M Buy
126,000
+121,024
+2,432% +$2.18M ﹤0.01% 3053
2025
Q4
$135K Sell
4,976
-1,551
-24% -$38.6K ﹤0.01% 4229
2025
Q3
$123K Buy
6,527
+3,430
+111% +$53.3K ﹤0.01% 4209
2025
Q2
$34K Buy
3,097
+2,158
+230% +$19.9K ﹤0.01% 4391
2025
Q1
$5.75K Sell
939
-572
-38% -$5.46K ﹤0.01% 4825
2024
Q4
$24.8K Buy
+1,511
New +$33.7K ﹤0.01% 4673

Other funds holding UPB

BNP Paribas Financial Markets's UPB Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Upstream Bio Inc (UPB) stake by 306% in Q2 2026, buying an estimated $3.23M and bringing the position to 511,546 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

BNP Paribas Financial Markets first reported a position in UPB in Q4 2024 and has held it in 7 quarters since. 135 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • BNP Paribas Financial Markets held 511,546 shares of Upstream Bio Inc worth $3.54M as of Q2 2026.
  • BNP Paribas Financial Markets bought 385,546 Upstream Bio Inc shares in Q2 2026, an estimated $3.23M.
  • Upstream Bio Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2376 holding.
  • BNP Paribas Financial Markets first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 7 quarters since.
  • 135 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.